References
- Garcia-Berrocal B, Gonzalez C, Perez M, Navajo JA, Moreta I, Davila C, et al. Anti-cyclic citrullinated peptide autoantibodies in IgM rheumatoid factor-positive patients. Clin Chim Acta 2005;354: 123–30.
- Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al. The diagnostic properties of rheu-matoid arthritis antibodies recognizing a cyclic citrullinated pep-tide. Arthritis Rheum 2000;43:155–63.
- Vander Cruyssen B, Hoffman IE, Zmierczak H, Van den Berghe M, Kruithof E, De Rycke L, et al. Anti-citrullinated peptide anti-bodies may occur in patients with psoriatic arthritis. Ann Rheum Dis 2005;64:1145–9.
- Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ. Citrulline is an essential constituent of anti-genic determinants recognized by rheumatoid arthritis-specific au-toantibodies. J Chin Invest 1998;101:273–81.
- Rus'd AA, Ikejiri Y, Ono H, Yonekawa T, Shiraiwa M, Kawada A, et al. Molecular cloning of cDNAs of mouse peptidylarginine deiminase type I, type III and type IV, and the expression pattern of type I in mouse. Eur J Biochem 1999;259: 660–9.
- Raza K, Breese M, Nightingale P, Kumar K, Potter T, Carruthers DM, et al. Predictive value of antibodies to cyclic citrullinated peptide in patients with very early inflammatory arthritis. J Rheumatol 2005;32:231–8.
- van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002;4: 87–93.
- van Venrooij WJ, Hazes JM, Visser H. Anticitrullinated protein/ peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 2002;60:383–8.
- Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Ftheumatol 1998;25: 1991–4.
- Woo P, Wedderburn LR. Juvenile chronic arthritis. Lancet 1998;351:969–73.
- Lawrence JM, III, Moore TL, Osborn TG, Nesher G, Madson KL, Kinsella MB. Autoantibody studies in juvenile rheumatoid arthri-tis. Semin Arthritis Rheum 1993;22:265–74.
- Av6in T, Cimaz R, Falcini F, Zulian F, Martini G, Simonini G, et al. Prevalence and clinical significance of anti-cyclic citrullinated pep-tide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2002;61:608–11.
- Hromadnikova I, Stechova K, Pavia V, Hridelova D, Houbova B, Voslarova S, et al. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis. Autoimmunity 2002;35: 397–401.
- Kasapçopur 0, Altun S, Asian M, Karaarslan S, Kamburoglu-Goksel A, Saribas S, et al. Diagnostic accuracy of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2004;63:1687–9.
- Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL. Determination of anti-cyclic citrullinated peptide anti-bodies in the sera of patients with juvenile idiopathic arthritis. J Ftheumatol 2004;31:1829–33.
- van Rossum M, van Soesbergen R, de Kort S, ten Cate R, Zwinderman AH, de Jong B, et al. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. J Ftheumatol 2003;30:825–8.
- Brunner J, Sitzmann FC. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis. Clin Exp Ftheumatol 2006;24:449–51.
- Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnos-tic accuracy of the anti-citrulline antibody assay for rheumatoid arthritis. Clin Chem 2001;47:1089–93.
- Lee DM, Schur PH. Clinical utility of the anti-CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003;62:870–4.
- Dijkmans BA, van Schaardenburg D, van der Horst-Bruinsma IE, Reesink HW, Vandenbroucke JP, Boers M. The predictive value of autoantibodies in disseminating lupus erythematosus and rheu-matoid arthritis. Ned Tijdschr Geneeskd 2005;149:688–93.
- Us D, Gulmez D, Hascelik G. Cyclic citrullinated peptide anti-bodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis. Mikrobiyol Bul 2003; 37:163–70.